About: Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $10.46 (+1.06%)
XERS NASDAQ Xeris Pharmaceuticals Inc
Xeris Pharmaceuticals Inc share price
XERS price activity
Last Price
$10.460
Change (24hr)
0.11 USD (1.06%)
Volume
3.14M
Volume (4w avg)
-
Open
$10.52
Day Range
$10.15 - $10.71
Previous Close
$10.35
Last Trade
04 Nov, 9:21 pm GMT+0
Delayed
04 Nov, 9:21 pm GMT+0
XERS price performance
Delayed
04 Nov, 9:21 pm GMT+0
XERS details
XERS Market Signals